Vitamin D Conversion by Sarcoid Lymph Node Homogenate

  1. REBECCA S. MASON, M.B., Ph.D.;
  2. THERESA FRANKEL, B.V.Sc., Ph.D.;
  3. YUK-LUEN CHAN, M.B.;
  4. DIANNE LISSNER; and
  5. SOLOMON POSEN, M.D.
  1. St. Leonards
    , Australia

    Abstract

    Recent studies suggest that hypercalcemia of sarcoidosis is due to high blood concentrations of calcitriol and that this compound may be synthesized at an extra-renal site. We report that sarcoid lymph node homogenate metabolized calcifediol to a substance indistinguishable from calcitriol, whereas six nonsarcoid lymph nodes failed to produce this compound.

    Article and Author Information

    • ▸From the Endocrine Unit. Royal North Shore Hospital; St. Leonards, New South Wales, Australia.

    • Grant support: The National Health and Medical Research Council of Australia, the New South Wales State Cancer Council, and the Coppleson Postgraduate Foundation of the University of Sydney.

    • ▸Requests for reprints should be addressed to Solomon Posen, M.D.; Endocrine Unit, Royal North Shore Hospital; St. Leonards, N.S.W., 2065, Australia.

    « Previous | Next Article »Table of Contents